HK$4.64
1.09%
Hong Kong, Oct 05, 01:25 pm HKT. Market open.
ISIN
KYG6981F1090
Symbol
9996

Peijia Medical Target price 2026 - Analyst rating & recommendation

Peijia Medical Classifications & Recommendation

Buy
90%
Hold
10%

Peijia Medical Price Target

Target Price HK$9.49
Price HK$4.59
Potential
Number of Estimates 6
6 Analysts have issued a price target Peijia Medical 2027 . The average Peijia Medical target price is HK$9.49. This is higher than the current stock price. The highest price target is
HK$11.22 144.81%
register free of charge
, the lowest is .
A rating was issued by 10 analysts: 9 Analysts recommend Peijia Medical to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Peijia Medical stock has an average upside potential 2027 of . Most analysts recommend the Peijia Medical stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million HK$ 834.35 1,098.16
15.82% 31.62%
EBITDA Margin -23.42% 13.55%
26.25% 157.85%
Net Margin -28.52% 0.98%
22.54% 103.44%

5 Analysts have issued a sales forecast Peijia Medical 2026 . The average Peijia Medical sales estimate is

HK$1.1b
unlock
. This is
19.68% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HK$1.1b 24.34%
unlock
, the lowest is
HK$1.0b 13.13%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$834m 15.82%
2026
HK$1.1b 31.62%
unlock
2027
HK$1.4b 27.89%
unlock
2028
HK$1.8b 26.58%
unlock
2029
HK$3.9b 118.24%
unlock
2030
HK$4.9b 25.13%
unlock
2031
HK$5.8b 19.05%
unlock

5 Peijia Medical Analysts have issued a net profit forecast 2026. The average Peijia Medical net profit estimate is

HK$10.7m
unlock
. This is
106.51% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HK$24.9m 115.08%
unlock
, the lowest is
HK$0.0 100.00%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$-238m 10.28%
2026
HK$10.7m 104.51%
unlock
2027
HK$132m 1,124.95%
unlock
2028
HK$294m 123.48%
unlock

Net Margin

2025 -28.52% 22.54%
2026
0.98% 103.44%
unlock
2027
9.37% 856.12%
unlock
2028
16.54% 76.52%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share HK$ -0.36 0.02
10.00% 105.56%
P/E 288.12
EV/Sales 2.84

5 Analysts have issued a Peijia Medical forecast for earnings per share. The average Peijia Medical EPS is

HK$0.02
unlock
. This is
108.00% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HK$0.04 116.00%
unlock
, the lowest is
HK$0.00 100.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$-0.36 10.00%
2026
HK$0.02 105.56%
unlock
2027
HK$0.19 850.00%
unlock
2028
HK$0.44 131.58%
unlock

P/E ratio

Current -18.34 16.68%
2026
288.12 1,670.99%
unlock
2027
23.51 91.84%
unlock
2028
10.52 55.25%
unlock

Based on analysts' sales estimates for 2026, the Peijia Medical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.40
2026
2.84 16.36%
unlock
2027
2.22 21.81%
unlock
2028
1.76 21.00%
unlock
2029
0.80 54.18%
unlock
2030
0.64 20.08%
unlock
2031
0.54 16.01%
unlock

P/S ratio

Current
2026
2.96 16.44%
unlock
2027
2.31 21.81%
unlock
2028
1.83 21.00%
unlock
2029
0.84 54.18%
unlock
2030
0.67 20.08%
unlock
2031
0.56 16.00%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today